Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

Market Analysis and Insights: Global Pemetrexed Market
The global Pemetrexed market is valued at US$ 1762.5 million in 2019. The market size will reach US$ 1856.5 million by the end of 2026, growing at a CAGR of 0.7% during 2021-2026.

Global Pemetrexed Scope and Market Size
Pemetrexed market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pemetrexed market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
100mg
500mg

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Company
Eli Lilly
Abbott Laboratories
Cadila Healthcare
Eagle Pharmaceuticals
Stada Arzneimittel

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia